J Korean Med Assoc Search


J Korean Med Assoc > Volume 54(9); 2011 > Article
Journal of the Korean Medical Association 2011;54(9):953-956.
DOI: https://doi.org/10.5124/jkma.2011.54.9.953   
Therapy for idiopathic precocious puberty in children
Kye Shik Shim, Jung Tae Kim
1Department of Pediatrics, Kyung Hee University School of Medicine, Seoul, Korea. 64sks@khnmc.or.kr
2Department of Pharmacy, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Pharmacy, Seoul, Korea.
The incidence of idiopathic precocious puberty is rapidly increasing in Korea. The most common medication used for treatment is a gonadotropin releasing hormone agonist. However, there is some debate regarding the indication and timing of treatment, and the dosage of the medication, because there are many factors that can affect growth in children after delaying puberty. Also, there are new medications that can potentially delay the puberty with children, for example, gonadotropin releasing hormone antagonists and aromatase inhibitors which require extensive further study.
Key Words: Precocious puberty, Gonadotropin-releasing hormone, Agonist


Browse all articles >

Editorial Office
Samgu B/D 7F, 40 Cheongpa-ro, Youngsan-gu, Seoul 04373, Korea
Tel: +82-1566-2844    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2022 by Korean Medical Association.

Developed in M2PI

Close layer
prev next